KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Depreciation & Amortization (CF) (2016 - 2025)

Quest Diagnostics' Depreciation & Amortization (CF) history spans 17 years, with the latest figure at $103.0 million for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) changed N/A year-over-year to $103.0 million; the TTM value through Dec 2025 reached $386.0 million, up 89.22%, while the annual FY2025 figure was $570.0 million, 15.62% up from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $103.0 million at Quest Diagnostics, down from $143.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $143.0 million in Q2 2025 and bottomed at $79.0 million in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $106.5 million (2021), against an average of $106.5 million.
  • The largest annual shift saw Depreciation & Amortization (CF) fell 21.78% in 2022 before it surged 62.5% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $106.0 million in 2021, then dropped by 23.58% to $81.0 million in 2022, then skyrocketed by 34.57% to $109.0 million in 2023, then dropped by 19.27% to $88.0 million in 2024, then grew by 17.05% to $103.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Depreciation & Amortization (CF) are $103.0 million (Q3 2025), $143.0 million (Q2 2025), and $140.0 million (Q1 2025).